Guru Ownership Trend
Guru Analysis for Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $52.11 M.
Top institutional holders include Jefferies Group and Steven Cohen.
Institutional sentiment is currently Bearish. This is evidenced by a $191.34 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 90.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Ultragenyx Pharmaceutical Inc. (RARE)
Major holders include Jefferies Group ($20.14 M), Steven Cohen ($12.69 M), Cliff Asness ($9.52 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.98 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $191.34 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 3 fully exited RARE. The total reported sell value was $212.64 M.
Yes, 3 managers opened new positions in RARE, and 1 increased their existing holdings. The total reported buy value was $21.29 M.